Stock Library / IDXX

IDXX Unclassified Latest YouTube: Q2 2026 Published 2026-08-04

IDXX

Live stock metrics, chart context, a quarter-by-quarter episode archive, and a deeper competitor comparison so this page behaves more like an investor workspace than a flat episode link page.

Latest on YouTube Latest on Podbean Apple Podcasts Amazon Music iHeartRadio YouTube Music Company Website Back to Library

Latest earnings video

IDEXX (IDXX): Vet Visits Are Falling, It Grew 11 Points Faster. Is IDXX Stock a Buy?

Published 2026-08-04

Open YouTube Spotify Show Open Podbean Apple Podcasts

Library coverage

Episodes tracked

1

Episodes linked

1

Latest video

Q2 2026

2026-08-04

Podcast available

Yes

Current price

$588.09

+14.46 (+2.52%)

Trailing / Forward P/E

42.62x

Forward: 35.61x

Market cap / Volume

—

Volume: —

Revenue / Earnings Growth

14.3%

Earnings: 17.2%

Margins

31.8% op

Gross: 62.1% · Net: 24.6%

Balance sheet

1.12x current

Debt / Equity: 71.0

52-week range / Beta

$518.55 - $769.98

Beta: 1.54

Analyst target

$707.00

Upside: 20.2%

Cash / shareholder return

1.70% FCF yield

Dividend yield: —

Company context

Industry: Diagnostics & Research

Country: United States

Employees: —

Price to book: 29.95x

Return on equity: 72.9%

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Price chart

Market context for IDXX

Competitive view

IDXX vs. two close competitors

This section compares the current company against two nearby peers on valuation, growth, margins, balance-sheet strength, and investment setup. Green generally marks the strongest relative figure for that row, while red marks the weakest.

IDXX latest YouTube video thumbnail

IDXX

IDXX

YouTube Podbean

Latest video

Q2 2026

Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.

Profitability is a real strength here, with healthy operating margins helping support resilience through weaker cycles.

Valuation already asks investors to pay up, so the upside case depends on continued execution staying strong.

Expect a more volatile ride than the market average; that can amplify upside, but drawdowns can come fast too.

SS&C Technologies Holdings Inc. latest YouTube video thumbnail

SS&C Technologies Holdings Inc.

SSNC

YouTube Podbean

Latest video

Q2 2026

Growth profile looks strong right now, with above-average top-line and/or earnings momentum.

Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.

Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.

Balance-sheet leverage is elevated, so investors should watch refinancing costs and how much flexibility management really has.

Palantir Technologies latest YouTube video thumbnail

Palantir Technologies

PLTR

YouTube Podbean

Latest video

Q2 2026

Growth profile looks strong right now, with above-average top-line and/or earnings momentum.

Profitability is a real strength here, with healthy operating margins helping support resilience through weaker cycles.

Valuation already asks investors to pay up, so the upside case depends on continued execution staying strong.

Expect a more volatile ride than the market average; that can amplify upside, but drawdowns can come fast too.

Market Cap

More scale can mean deeper resources and resilience, although bigger does not automatically mean better upside.

IDXX

$46.39B

IDXX

SSNC

$19.02B

SS&C Technologies Holdings Inc.

PLTR

$390.88B

Palantir Technologies

Trailing P/E

Lower trailing P/E can indicate a cheaper valuation relative to trailing earnings, but it may also reflect slower growth or higher perceived risk.

IDXX

42.6x

IDXX

SSNC

22.8x

SS&C Technologies Holdings Inc.

PLTR

182.8x

Palantir Technologies

Forward P/E

Forward P/E is often a better read on what investors are paying for the next year of earnings power.

IDXX

35.6x

IDXX

SSNC

10.5x

SS&C Technologies Holdings Inc.

PLTR

77.7x

Palantir Technologies

Revenue Growth

Higher revenue growth usually signals stronger demand, market share gains, or a business still in expansion mode.

IDXX

14.3%

IDXX

SSNC

10.3%

SS&C Technologies Holdings Inc.

PLTR

84.7%

Palantir Technologies

Earnings Growth

Faster earnings growth matters because it shows management is converting sales momentum into shareholder value.

IDXX

17.2%

IDXX

SSNC

34.7%

SS&C Technologies Holdings Inc.

PLTR

325.0%

Palantir Technologies

Operating Margin

Higher operating margin suggests better operating discipline, pricing power, or a structurally stronger business model.

IDXX

31.8%

IDXX

SSNC

24.6%

SS&C Technologies Holdings Inc.

PLTR

46.2%

Palantir Technologies

Gross Margin

Gross margin helps show how much product-level pricing power and unit economics a company has before overhead.

IDXX

62.1%

IDXX

SSNC

48.1%

SS&C Technologies Holdings Inc.

PLTR

84.1%

Palantir Technologies

Net Margin

Higher net margin means more of each dollar of revenue reaches the bottom line after all costs.

IDXX

24.6%

IDXX

SSNC

13.2%

SS&C Technologies Holdings Inc.

PLTR

43.7%

Palantir Technologies

Return on Equity

ROE shows how efficiently management turns shareholder capital into profits, though leverage can inflate it.

IDXX

72.9%

IDXX

SSNC

12.6%

SS&C Technologies Holdings Inc.

PLTR

32.6%

Palantir Technologies

Free Cash Flow Yield

Higher free cash flow yield can indicate a stronger cash return relative to the stock's market value.

IDXX

1.7%

IDXX

SSNC

6.8%

SS&C Technologies Holdings Inc.

PLTR

0.5%

Palantir Technologies

Debt to Equity

Lower leverage usually means less balance-sheet risk, though capital-intensive sectors naturally run higher debt loads.

IDXX

71.04x

IDXX

SSNC

115.90x

SS&C Technologies Holdings Inc.

PLTR

2.48x

Palantir Technologies

Current Ratio

A stronger current ratio usually signals better short-term liquidity and more room to absorb shocks.

IDXX

1.12x

IDXX

SSNC

1.06x

SS&C Technologies Holdings Inc.

PLTR

6.91x

Palantir Technologies

Beta

Lower beta often means lower volatility versus the market, while higher beta usually brings a rougher ride.

IDXX

1.54

IDXX

SSNC

1.09

SS&C Technologies Holdings Inc.

PLTR

1.56

Palantir Technologies

Dividend Yield

Dividend yield matters for income-focused investors, but a high yield can also reflect a stressed stock price.

IDXX

—

IDXX

SSNC

1.4%

SS&C Technologies Holdings Inc.

PLTR

—

Palantir Technologies

Analyst Upside

Higher analyst upside suggests the Street still sees room between current price and consensus fair value.

IDXX

20.2%

IDXX

SSNC

13.9%

SS&C Technologies Holdings Inc.

PLTR

14.2%

Palantir Technologies

Related research

Non-quarter videos featuring IDXX

Special-topic videos, explainers, and shorts connected to this ticker.

All Research Sections

Shorts and Clips 2026-08-04

IDEXX: Vet Visits Are FALLING, It Grew 11 Points Faster #IDXX #stocks

A fast Charged Alpha clip pointing viewers into the latest earnings coverage.

YouTube

Episode timeline

Episode archive for IDXX

Each row is one earnings episode with every verified platform link available.

Q2 2026

Episode live

2026-08-04

Published youtube podcast complete

IDEXX (IDXX): Vet Visits Are Falling, It Grew 11 Points Faster. Is IDXX Stock a Buy?

Quarterly earnings-analysis entry for IDXX. Use the links on the right to open the video or podcast episode.

YouTube Spotify Show Podcast Apple Podcasts Amazon Show iHeart Show YouTube Music